EWL:ETR
Edwards Lifesciences Corp
€76.42
arrow_downward
-1.29%(-1.00) 1D
Oct 8, 1:17:48 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EWL...
Open
€77.12
High
€77.12
Low
€76.42
Mkt. cap
47.67B
Avg. vol.
61.00
Volume
0.00
52-wk high
€84.00
52-wk low
€62.00
No. of employees
16K
Open
€77.12
High
€77.12
Low
€76.42
Mkt. cap
47.67B
Avg. vol.
61.00
Volume
0.00
52-wk high
€84.00
52-wk low
€62.00
No. of employees
16K
News stories
From web sources and news partners
Traders Union
·
15 minutes ago
Edwards Lifesciences shares drop around 3.5% after FDA valve approval fails to stem selling pressure
Investing.com
·
40 minutes ago
UBS reiterates Edwards Lifesciences stock rating on endpoint expectations
MarketBeat
·
5 hours ago
Edwards Lifesciences (NYSE:EW) Stock Rating Upgraded by Barclays
The National Law Review
·
1 day ago
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Websiteedwards.com